Senior Healthcare Consultant
Milliman
Indianapolis, IN
Brenda Cordell is a Senior Healthcare Consultant in the Indianapolis Health Practice of Milliman. She joined the firm in 2008 and is a lead in Milliman's life sciences consulting group. Brenda is also co-creator of Milliman DNA Gene and Cell Therapy Forecasting, a dynamic, web-based application that estimates the associated costs and cases for approved and pipeline gene and cell therapies. Brenda leads the clinical, market and economic research that form the baseline assumptions in this application and its associated research repository. With over 25 years of experience in leadership roles within life sciences companies and at Milliman, Brenda's focus areas are market access, payer strategy, market intelligence and financial analysis specifically in rare disease and novel therapies.
Brenda has authored several white papers and reports, some of which have been published by the Journal of Managed Care & Specialty Pharmacy (JMCSP). She has also presented at AMCP and Self-Insurance Institute of America (SIIA). She is a member of the SIIA Cell & Gene Therapy Task Force.
Wednesday, April 2, 2025
4:15 PM – 5:30 PM CST